People
Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer.
The American University Washington College of Law and the Food and Drug Law Institute hosted a conference late last week. One of the highlights was a plenary session that featured former commissioners of the U.S. Food and Drug Administration (FDA).
Anticipated Funding Opportunities for Fiscal Year 2019 (FY19)
Execs at Novo Nordisk, AbbVie, and more made moves this week. Here’s a roundup of those changes.
Martyn Webster joins as CFO; Sean Shirvani, MD, joins as VP of Medical Affairs; Judy Bartlett-Roberto joins as VP of Marketing; Partha Ray joins as VP of Innovation Strategy; Len Lyons joins as VP of Sales
TIME Magazine came out with a list of the 50 most influential people in healthcare, dubbed The Health Care 50. A look through the list shows just how many ties and connections—as well as influence—this group has on the biopharma industry.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers. Name one influencer in the life sciences industry that produced a significant impact in 2018.
Every year, the Breakthrough Prize Foundation awards a collective total of $22 million to nine researchers for achievements in the Life Sciences, Fundamental Physics and Mathematics.
Citing structural simplification, Pfizer announced it plans to cut its global staffing by about 2 percent. It expects to do so primarily through voluntary layoffs and early retirement through the end of this year and early in 2019.
VisionGate, Inc. is pleased to announce the appointment of R. John Glasspool as its Chief Operating and Strategy Officer.
PRESS RELEASES